Clinica Baviera(CH:D9Z)
CH:D9Z
Clinica Baviera stock forecast
Clinica Baviera (D9Z) Stock Forecast & Price Target
0 Followers
D9Z Analyst Ratings
Moderate Buy
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Clinica Baviera in the past 3 months
D9Z Stock 12 Month Forecast
Average Price Target
CHF65.77▲(0.00% Upside)Based on 1 Wall Street analysts offering 12 month price targets for Clinica Baviera in the last 3 months. The average price target is CHF 65.77 with a high forecast of CHF 65.77 and a low forecast of CHF 65.77. The average price target represents a ― change from the last price of ―.
Highest Price TargetHighestCHF65.77Average Price TargetCHF65.77Lowest Price TargetLowestCHF65.77
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
D9Z Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 1 | 1 | 1 | 0 |
In the current month, D9Z has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. D9Z average Analyst price target in the past 3 months is 65.77.
D9Z Financial Forecast
Consensus$0.00
D9Z Sales Forecast
Next quarter’s sales forecast for D9Z is $0 with a range of ― to ―. The previous quarter’s sales results were $76.62M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
D9Z Stock Forecast FAQ
What is CH:D9Z’s average 12-month price target, according to analysts?
Based on analyst ratings, Clinica Baviera’s 12-month average price target is CHF65.77.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Clinica Baviera a Buy, Sell or Hold?
Clinica Baviera has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Clinica Baviera’s share price target?
The average share price target for Clinica Baviera is CHF65.77. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF65.77, and the lowest forecast is CHF65.77. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Clinica Baviera?
Clinica Baviera’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Clinica Baviera?
To buy shares of CH:D9Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
